2771 - 2780 of 8808 Results
Title
Year
-
OPENTitle: The unfolded protein response is activated in the olfactory system in Alzheimer’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-020-00986-7Best OA location URL: http://hdl.handle.net/2292/52610Citation Count: 37
-
OPENTitle: Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP BiosensorJournal Name: Molecular PharmacologyPublisher: Elsevier BVVol: 74Issue #: 3Start Page: 585End Page: 594Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1124/mol.108.048884Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3766527Citation Count: 149
- BAX inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response2011OPENTitle: BAX inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein responseJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 30Issue #: 21Start Page: 4465End Page: 4478Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/emboj.2011.318Best OA location URL: https://repositorio.uchile.cl/handle/2250/165394Citation Count: 112
- Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson’s disease2025OPENTitle: Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 44Issue #: 3Start Page: 115355End Page: 115355Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2025.115355Best OA location URL: https://www.cell.com/action/showPdf?pii=S2211124725001263Citation Count: 2
-
OPENTitle: Open science takes on Parkinson’s diseaseJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.66546Best OA location URL: https://doi.org/10.7554/elife.66546Citation Count: 7
-
OPENTitle: Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tauJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 125Issue #: 2Start Page: 681End Page: 686Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci78421Best OA location URL: http://doi.org/10.1172/JCI78421Citation Count: 194
-
OPENTitle: Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease modelsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 3Issue #: 3-4Start Page: 194End Page: 208Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/dmm.004267Best OA location URL: http://doi.org/10.1242/dmm.004267Citation Count: 178
-
OPENTitle: A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 16Start Page: 1229End Page: 1236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182516244Best OA location URL: https://n.neurology.org/content/neurology/78/16/1229.full.pdfCitation Count: 325
-
OPENTitle: Genetic variants and functional pathways associated with resilience to Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 8Start Page: 2561End Page: 2575Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awaa209Best OA location URL: https://academic.oup.com/brain/article-pdf/143/8/2561/37356057/awaa209.pdfCitation Count: 126
-
OPENTitle: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2Journal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adt2050Best OA location URL: https://doi.org/10.1126/sciadv.adt2050Citation Count: 0